The “Global Facial Fat Transfer Market (2019-2025)” report has been added to ResearchAndMarkets.com’s offering.
The Global Facial Fat Transfer Market size is expected to reach3.5 billion by 2025, rising at a market growth of 10.4% CAGR during the forecast period.
Facial fat transfer is also referred to as fat injection, fat grafting, or lipofilling. This is done by using the patient’s body fat from the thighs, hips, or stomach to add volume to the face. Facial fat transfer is commonly done to restore sunken cheeks and hollow eyes, reduce wrinkles, thin lips, smooth deep nasolabial folds, and redefine the face. The industry is growing at a rapid pace owing to an increased demand for facial fat transfer procedure, advanced facial rejuvenation technology, and a growing aging population.
Facial fat injections may reduce parts of the facial “wear and tear” that are commonly shown with age, such as frown lines, marionette lines, smile lines, furrows and wrinkles, and hollows in the face, for example, under the cheekbones or the eyes. Lips with a lack of volume can also be treated by fat transfer, such as scars or depressions in the face from scars, such as those from the skin break out. People with at least one of these conditions may be good candidates for autologous fat transfer. Fat recovery time differs from patient to patient; however, most people should take a minimum of 7-10 days off from work and other social activities. The initial healing will take a few weeks, after which the swelling will slowly decrease before the final results are evident. Although the recovery period is relatively mild for fat transfer, patients must allow ample time to heal properly. Patients should see final results after about six months, while progress will begin to become evident just a few days after surgery.
The facial fat transfer market has gained immense market momentum due to its wide range of benefits to the patients. For example, since the fat used for grafting is derived from the patient’s own body, there is almost no possibility of an adverse reaction, whereas the dermal filler-based hyaluronic acid has a possible risk of causing several allergic reactions. These benefits are also expected to drive the facial fat transfer market over the forecast period. Facial implant recovery is also a relatively mild process that needs at least a week of rest time before returning to work and other day-to-day activities. Exercise will be limited for a few weeks, and although the results should be immediately apparent, swelling will hinder the final results of the procedure at first. Swelling should begin to subside gradually and be fully resolved by approximately six months following the procedure.
Based on Donor Site, the market is segmented into Flank, Thigh and Abdomen. Based on End Use, the market is segmented into Clinics & surgery centers and Hospitals. Based on Regions, the market is segmented into North America, Europe, Asia Pacific, and Latin America, Middle East & Africa.
Key Topics Covered:
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.3 Market Scope
1.4.1 Global Facial Fat Transfer Market, by Donor Site
1.4.2 Global Facial Fat Transfer Market, by End Use
1.4.3 Global Facial Fat Transfer Market, by Geography
1.5 Methodology for the research
Chapter 2. Market Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Global Facial Fat Transfer Market by Donor Site
3.1 Global Flank Facial Fat Transfer Market by Region
3.2 Global Thigh Facial Fat Transfer Market by Region
3.3 Global Abdomen Facial Fat Transfer Market by Region
Chapter 4. Global Facial Fat Transfer Market by End-Use
4.1 Global Clinics & surgery centers Market by Region
4.2 Global Hospitals Market by Region
Chapter 5. Global Facial Fat Transfer Market by Region
5.1 North America Facial Fat Transfer Market
5.2 Europe Facial Fat Transfer Market
5.3 Asia Pacific Facial Fat Transfer Market
5.4 LAMEA Facial Fat Transfer Market
Chapter 6. Company Profiles
6.1 Allergan PLC
6.2 Integra LifeSciences Holdings Corporation
6.3 Bausch Health Companies, Inc.
6.4 Ipsen Pharma Biotech SAS
6.5 Ranfac Corporation
6.6 Cytori Therapeutics, Inc.
6.7 Suneva Medical, Inc.
6.8 Dr. Korman Laboratories Ltd.
6.9 Scivision Biotech, Inc.
6.10 Teoxane Laboratories SA
For more information about this report visit https://www.researchandmarkets.com/r/8q9nfp